Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Sleepwalking and Sleep Talking01:17

Sleepwalking and Sleep Talking

665
Somnambulism, commonly known as sleepwalking, involves individuals engaging in activities ranging from simple walking to more complex behaviors such as driving. Sleepwalking typically occurs during the slow-wave sleep stages 3 and 4 early in the night when the person is not dreaming, contradicting the myth that sleepwalkers are acting out their dreams.
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
665
Restless Leg Syndrome and Night Terrors01:27

Restless Leg Syndrome and Night Terrors

409
Restless Leg Syndrome (RLS), also known as Willis-Ekbom disease, is a neurological disorder characterized by an uncontrollable urge to move the legs due to uncomfortable sensations. These sensations typically occur during periods of rest or inactivity, particularly when lying down or sitting, and can severely disrupt sleep.
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
409
Narcolepsy01:07

Narcolepsy

401
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
401
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

418
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
418
Sleep-Wake Cycles01:24

Sleep-Wake Cycles

2.6K
Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and  rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
2.6K
Management of Insomnia01:19

Management of Insomnia

441
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
441

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treatment-Seeking for Children with Suspected Severe Malaria Attending Community Health Workers and Primary Health Centres in Adamawa State, Nigeria.

International journal of public health·2025
Same author

Establishing a Multicenter Active Adverse Events Following Immunization Sentinel Surveillance Network Across 22 Tertiary Care Hospitals in India: Protocol for a Prospective Observational Study.

JMIR research protocols·2025
Same author

Multiple first-line therapeutic strategies to mitigate artemisinin resistance: cost analysis of a pilot study from a health system perspective in Kaya health district, Burkina Faso.

Malaria journal·2025
Same author

Building functional and sustainable pharmacovigilance systems: an analysis of pharmacovigilance development across high-, middle- and low-income countries.

Therapeutic advances in drug safety·2025
Same author

Pharmacovigilance processes in low- and middle-income countries: moving from data collection to data analysis and interpretation.

Therapeutic advances in drug safety·2025
Same author

Indigenous emergence and spread of <i>kelch13</i> C469Y artemisinin-resistant <i>Plasmodium falciparum</i> in Uganda.

Antimicrobial agents and chemotherapy·2024

Related Experiment Video

Updated: Dec 24, 2025

Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System
05:59

Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System

Published on: October 20, 2023

2.9K

Sleeping Sickness at the Crossroads.

Christian Burri1,2

  • 1Swiss Tropical and Public Health Institute, Socinstrasse 57, 4002 Basel, Switzerland.

Tropical Medicine and Infectious Disease
|April 12, 2020
PubMed
Summary

Human African trypanosomiasis (HAT), or sleeping sickness, is a historic disease. This research delves into its complex dimensions and implications.

Area of Science:

  • Neglected tropical diseases
  • Parasitology
  • Public health

Background:

  • Human African trypanosomiasis (HAT), also known as sleeping sickness, is a vector-borne parasitic disease with significant historical and global health implications.
  • The disease is caused by Trypanosoma parasites transmitted by the tsetse fly, primarily affecting rural and impoverished populations in sub-Saharan Africa.
  • Understanding the complex epidemiology and pathogenesis of HAT is crucial for effective control and elimination strategies.

Discussion:

  • HAT presents a significant challenge due to its complex life cycle, diagnostic difficulties, and the need for specialized treatment.
  • Socioeconomic factors, environmental changes, and population movement influence HAT transmission dynamics.
  • The historical burden of HAT underscores the persistent need for sustained research and intervention efforts.

More Related Videos

Author Spotlight: AI-Driven Trypanosome Species Detection from Microscopic Images
08:20

Author Spotlight: AI-Driven Trypanosome Species Detection from Microscopic Images

Published on: October 27, 2023

2.3K
Bioluminescence Imaging to Detect Late Stage Infection of African Trypanosomiasis
07:59

Bioluminescence Imaging to Detect Late Stage Infection of African Trypanosomiasis

Published on: May 18, 2016

8.1K

Related Experiment Videos

Last Updated: Dec 24, 2025

Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System
05:59

Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System

Published on: October 20, 2023

2.9K
Author Spotlight: AI-Driven Trypanosome Species Detection from Microscopic Images
08:20

Author Spotlight: AI-Driven Trypanosome Species Detection from Microscopic Images

Published on: October 27, 2023

2.3K
Bioluminescence Imaging to Detect Late Stage Infection of African Trypanosomiasis
07:59

Bioluminescence Imaging to Detect Late Stage Infection of African Trypanosomiasis

Published on: May 18, 2016

8.1K

Key Insights:

  • HAT remains a critical public health concern, demanding continued attention and resources.
  • The multifaceted nature of HAT requires integrated approaches combining entomological surveillance, early diagnosis, and effective treatment.
  • Further research into parasite biology, vector control, and host-parasite interactions is essential for advancing HAT elimination goals.

Outlook:

  • Continued efforts in disease surveillance and vector control are vital for reducing HAT incidence.
  • Development of improved diagnostics and therapeutics will enhance patient outcomes and treatment accessibility.
  • Global collaboration and sustained funding are imperative to achieve the ultimate goal of HAT eradication.